Kathleen Tregoning

CIK 1830764 · See Remarks · last filed 2026-05-29

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$213.8K

Companies

4

Total Filings

17

Lifetime Open-Market Net

-$260.5K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
CMPS Director $12.08 $0 1 2026-05-29
SPRO Director 75,000 $2.85 $213.8K $0 8 2025-06-16
Cerevel Therapeutics Holdings, Inc. (CERE) Delisted See Remarks 10,666 $44.96 $479.5K -$260.5K 5 2024-01-23
Cerevel Therapeutics Holdings, Inc. (CEREW) Delisted See Remarks $18.07 $0 2 2021-02-05

Recent Filings · Page 2 of 2

17 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2023-01-05 SPRO Grant (A) $0 EDGAR
2022-09-19 SPRO Grant (A) +15,000 $0 EDGAR
2022-02-11 Cerevel Therapeutics Holdings, Inc. (CERE) Delisted Grant (A) $0 EDGAR
2022-01-07 SPRO Grant (A) $0 EDGAR
2021-11-12 SPRO Grant (A) $0 EDGAR
2021-02-05 Cerevel Therapeutics Holdings, Inc. (CEREW) Delisted Grant (A) $0 EDGAR
2020-12-08 Cerevel Therapeutics Holdings, Inc. (CEREW) Delisted Grant (A) $0 EDGAR
Showing 1117 of 17
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.